Growth Metrics

IGC Pharma (IGC) Depreciation and Depletion (2018 - 2025)

IGC Pharma has reported Depreciation and Depletion over the past 12 years, most recently at $105000.0 for Q3 2025.

  • Quarterly Depreciation and Depletion fell 27.59% to $105000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $512000.0 through Sep 2025, down 10.65% year-over-year, with the annual reading at $567000.0 for FY2025, 0.71% up from the prior year.
  • Depreciation and Depletion was $105000.0 for Q3 2025 at IGC Pharma, down from $127000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $200000.0 in Q1 2022 and troughed at -$49000.0 in Q1 2023.
  • The 5-year median for Depreciation and Depletion is $144000.0 (2024), against an average of $135000.0.
  • Year-over-year, Depreciation and Depletion plummeted 124.5% in 2023 and then skyrocketed 397.96% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $117000.0 in 2021, then surged by 35.04% to $158000.0 in 2022, then decreased by 11.39% to $140000.0 in 2023, then rose by 2.86% to $144000.0 in 2024, then fell by 27.08% to $105000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Depreciation and Depletion are $105000.0 (Q3 2025), $127000.0 (Q2 2025), and $136000.0 (Q1 2025).